Hereditary red blood cell disorders in middle eastern patients

Area of Science:

• Hematology
• Genetics
• Internal Medicine

Background:

• Inherited erythrocyte disorders are prevalent in the Middle East, with carrier rates exceeding 10% in some regions.
• Unrecognized hereditary red blood cell conditions in Middle Eastern patients can lead to severe complications, particularly drug-induced hemolytic crises.
• These disorders pose significant clinical challenges when patients seek healthcare in Western countries.

Purpose of the Study:

• To review common and important inherited red blood cell disorders in patients from the Middle East.
• To provide guidance on recognizing, diagnosing, and managing these conditions.
• To highlight strategies for avoiding potential medical complications.

Main Methods:

• Literature review focusing on prevalent inherited erythrocyte disorders in Middle Eastern populations.
• Discussion of clinical suspicion, diagnostic approaches, and complication avoidance.
• Overview of general management principles for these conditions.

Main Results:

• Identified glucose-6-phosphate dehydrogenase deficiency, thalassemias, and sickle cell disorders as key inherited erythrocyte conditions.
• Emphasized the importance of clinical awareness for early detection.
• Outlined methods for diagnosis and strategies to prevent adverse events.

Conclusions:

• Inherited erythrocyte disorders are a significant health concern in Middle Eastern populations.
• Awareness and appropriate diagnostic measures are essential for safe medical care.
• Proactive management can mitigate the risks associated with these conditions.